EditorialCreativeSportKollektionenVideos
Preise
0Anmelden

Visuelle Inhalte für Profis.
800 Mio.+ Bilder und Videos.

Content-Hub

  • Aktuelle Ereignisse
  • Bilder des Jahres
  • Sport
  • Editorial
  • Creative
  • Kollektionen
  • Videos

Angebote

  • Preise & Pakete
  • Aktionen
  • Enterprise
  • Newsletter
  • Blog
  • The Game Magazine

Services

  • Bildrecherche
  • Auftragsfotografie
  • API & FTP Push
  • my-picturemaxx
  • Partner werden

Unternehmen

  • Über IMAGO
  • Karriere
  • News

Hilfe-Center

  • FAQ
  • Kontakt
ImpressumNutzungsbedingungenLizenzinformationenDatenschutzDatenschutzeinstellungen
© 2026 IMAGO
CEPICBAPLABVPA
  3. Coronavirus, Janssen Biologics in Leiden, Niederlande

Coronavirus, Janssen Biologics in Leiden, Niederlande

31.03.2020

Die folgenden Fotos wurden von der IMAGO Bildredaktion zu diesem Thema für Sie ausgewählt. Für weitere Bilder nutzen Sie bitte die Suchfunktion.

Bilder in dieser Kollektion

  • 31-03-2020 Exterior of Janssen Biologics B.V. initiate. Janssen Biologics B.V. makes, acquires and markets unique biopharmaceutical drugs. To prevent a potential pandemic, Johnson & Johnson initiated a project to develop a preventive coronavirus vaccine, Covid19, to potentially protect people from the disease. In doing so, they build on their leadership position in the development of monoclonal antibodies. Antibodies are substances that the body produces in response to bacteria, viruses or other foreign substances. Janssen Biologics innovative products focus on three main disease categories: cardiovascular and immunological disorders and cancer. Copyright: xPPEx

    31-03-2020 Exterior of Janssen Biologics B.V. initiate. Janssen Biologics B.V. makes, acquires and markets unique biopharmaceutical drugs. To prevent a potential pandemic, Johnson & Johnson initiated a project to develop a preventive coronavirus vaccine, Covid19, to potentially protect people from the disease. In doing so, they build on their leadership position in the development of monoclonal antibodies. Antibodies are substances that the body produces in response to bacteria, viruses or other foreign substances. Janssen Biologics innovative products focus on three main disease categories: cardiovascular and immunological disorders and cancer. Copyright: xPPEx

  • 31-03-2020 Exterior of Janssen Biologics B.V. initiate. Janssen Biologics B.V. makes, acquires and markets unique biopharmaceutical drugs. To prevent a potential pandemic, Johnson & Johnson initiated a project to develop a preventive coronavirus vaccine, Covid19, to potentially protect people from the disease. In doing so, they build on their leadership position in the development of monoclonal antibodies. Antibodies are substances that the body produces in response to bacteria, viruses or other foreign substances. Janssen Biologics innovative products focus on three main disease categories: cardiovascular and immunological disorders and cancer. Copyright: xPPEx

    31-03-2020 Exterior of Janssen Biologics B.V. initiate. Janssen Biologics B.V. makes, acquires and markets unique biopharmaceutical drugs. To prevent a potential pandemic, Johnson & Johnson initiated a project to develop a preventive coronavirus vaccine, Covid19, to potentially protect people from the disease. In doing so, they build on their leadership position in the development of monoclonal antibodies. Antibodies are substances that the body produces in response to bacteria, viruses or other foreign substances. Janssen Biologics innovative products focus on three main disease categories: cardiovascular and immunological disorders and cancer. Copyright: xPPEx

  • 31-03-2020 Exterior of Janssen Biologics B.V. initiate. Janssen Biologics B.V. makes, acquires and markets unique biopharmaceutical drugs. To prevent a potential pandemic, Johnson & Johnson initiated a project to develop a preventive coronavirus vaccine, Covid19, to potentially protect people from the disease. In doing so, they build on their leadership position in the development of monoclonal antibodies. Antibodies are substances that the body produces in response to bacteria, viruses or other foreign substances. Janssen Biologics innovative products focus on three main disease categories: cardiovascular and immunological disorders and cancer. Copyright: xPPEx

    31-03-2020 Exterior of Janssen Biologics B.V. initiate. Janssen Biologics B.V. makes, acquires and markets unique biopharmaceutical drugs. To prevent a potential pandemic, Johnson & Johnson initiated a project to develop a preventive coronavirus vaccine, Covid19, to potentially protect people from the disease. In doing so, they build on their leadership position in the development of monoclonal antibodies. Antibodies are substances that the body produces in response to bacteria, viruses or other foreign substances. Janssen Biologics innovative products focus on three main disease categories: cardiovascular and immunological disorders and cancer. Copyright: xPPEx

  • 31-03-2020 Exterior of Janssen Biologics B.V. initiate. Janssen Biologics B.V. makes, acquires and markets unique biopharmaceutical drugs. To prevent a potential pandemic, Johnson & Johnson initiated a project to develop a preventive coronavirus vaccine, Covid19, to potentially protect people from the disease. In doing so, they build on their leadership position in the development of monoclonal antibodies. Antibodies are substances that the body produces in response to bacteria, viruses or other foreign substances. Janssen Biologics innovative products focus on three main disease categories: cardiovascular and immunological disorders and cancer. Copyright: xPPEx

    31-03-2020 Exterior of Janssen Biologics B.V. initiate. Janssen Biologics B.V. makes, acquires and markets unique biopharmaceutical drugs. To prevent a potential pandemic, Johnson & Johnson initiated a project to develop a preventive coronavirus vaccine, Covid19, to potentially protect people from the disease. In doing so, they build on their leadership position in the development of monoclonal antibodies. Antibodies are substances that the body produces in response to bacteria, viruses or other foreign substances. Janssen Biologics innovative products focus on three main disease categories: cardiovascular and immunological disorders and cancer. Copyright: xPPEx

Kollektionen